Study on the incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis clinical isolates

Abstract

Abstract: Objective To determine the incidence of cross resistance between rifampicin and rifabutin by testing the minimal inhibitory concentrations(MICs) of rifampicin and rifabutin against Mycobacterium tuberculosis(M.tuberculosis) clinical isolates.Methods The liquid dilution method was performed to detect MICs of rifampicin and rifabutin in 116 M.tuberculosis clinical isolates.Results Rifabutin was susceptible to all isolates which were susceptible to rifampicin.Cross resistance between rifampicin and rifabutin w...

Key words: Rifabutin, Rifampicin, Cross resistance, MIC

CLC Number:

HAN Xi-Qin, HUANG Hai-Rong, LI Yan-Jing, YU Xia, BI Zhi-Qiang, CHU Nai-Hui, MA Yu. Study on the incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis clinical isolates[J]. Chinese Journal of Antituberculosis, 2010, 32(11): 740-743.

[1]	Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
[2]	Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163.
[3]	You Chengdong, Zhu Ling, Li Peibo. Research progress on serum trace elements in the development and nutritional support of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 218-223.
[4]	Zhong Lingshan, Wang Li, Zhang Shuo, Li Nan, Yang Qingyuan, Ding Wenlong, Chen Xingzhi, Huang Chencui, Xing Zhiheng. A machine learning model based on CT images combined with radiomics and semantic features for diagnosis of nontuberculous mycobacterium lung disease and pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1042-1049.
[5]	Geng Zimei, Wang Chaohong, Long Sibo, Zheng Maike, Shi Yiheng, Sun Yong, Zhao Yan, Wang Guirong. Analysis of bacteriological positivity and rifampicin resistance in patients with severe pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1050-1055.
[6]	Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei. Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
[7]	Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong. Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
[8]	Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei. Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950.
[9]	Du Yuhua, Feng Yajuan, Lei Yu, Lai Keng, He Weiyun. Analysis of the detection and treatment of rifampicin-resistant pulmonary tuberculosis patients in Guangzhou during the “12th Five-Year Plan” and “13th Five-Year Plan” periods [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 678-686.
[10]	Cheng Mengli, Jiang Guanglu, Huo Fengmin, Xue Yi, Yu Xia. Evaluation of in vitro activity of fusidic acid against mycobacteria [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 461-466.
[11]	Pei Shaojun, Ou Xichao. Interpretation of the World Health Organization’s Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 260-266.
[12]	Pan Ben, Liang Changhua, Han Dongming, Cui Junwei, Yao Yangyang, Wei Zhengqi, Zhen Siyu, Wei Hanyu, Yang Xinmiao. Model construction and validation for predicting active drug-resistant pulmonary tuberculosis using combined CT radiomics and clinical features [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 294-301.
[13]	Yao Yangyang, Liang Changhua, Han Dongming, Cui Junwei, Pan Ben, Wang Huihui, Wei Zhengqi, Zhen Siyu, Wei Hanyu. Differentiation of pulmonary tuberculosis and nontuberculous mycobacterial pulmonary disease based on computed tomography radiomics combined with clinical features [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 302-310.
[14]	Ge Jing, Wang Jun, He Yuqi, Nie Wenjuan. Six cases of pseudomembranous colitis caused by anti-tuberculosis drugs and literature review [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1320-1326.
[15]	Li Jing, Jiang Qi, Jiang Yuan, Shen Xin. Evaluation of performance of PCR fluorescent probe method for detecting Mycobacterium tuberculosis complex and rifampicin resistance [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1250-1258.

Study on the incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis clinical isolates

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments